GLP-1 Therapy or Bariatric Surgery

These two options get compared as if they were competing. GLP-1 or bariatric surgery is really a question about scale, and the two answer the problem at different scales, and for some people the answer is both, at different times. iLIV does not perform bariatric surgery. This page explains the difference so you can ask the right questions when you see a bariatric team.

GLP-1 or bariatric surgery, how each one works

GLP-1 therapy works on signalling. It mimics a gut hormone, extends fullness, and slows stomach emptying. The effect depends on the medicine being present. Bariatric surgery permanently changes the structure of the digestive tract, which also changes gut hormones, but that change does not depend on a weekly or daily dose.

Reversibility

This is the most practical difference. GLP-1 therapy can be stopped. When it stops, the signalling returns to where it was and appetite recovers, so the maintenance phase has to be planned from the start. Surgery cannot be undone. Some procedures can be revised, but you do not return to the original anatomy.

Long-term monitoring burden

After bariatric surgery, absorption of several nutrients is permanently affected. Vitamin B12, iron, calcium, vitamin D and folate need monitoring and supplementation for life, not for a year. On GLP-1 therapy, monitoring focuses on body composition, metabolic markers, and digestive side effects. Both need follow-up. What differs is the kind and the duration.

Who is usually referred for surgery

Referral criteria are set in clinical guidelines and assessed by a bariatric team, not by a single number. What gets weighed is the degree of obesity, which weight-related conditions are already present and how severe they are, the results of previous non-surgical attempts, surgical and anaesthetic risk, and readiness for long-term follow-up. If you are in that territory, ask for a referral rather than an opinion from the internet.

When they are not separate choices

Medication and surgery are not opposing camps. Medicine is sometimes used before surgery to reduce risk, and used after surgery when weight returns some years later. The right decision rests on your numbers, your history of previous attempts, and what you can actually sustain. See the metabolic assessment and body composition test for the baseline needed before any decision. Read who is eligible for GLP-1 therapy and why weight loss medication is not the easy way as well. Book a consultation for an assessment.

Questions worth asking before choosing

• What has already been tried, for how long, and what were the objective results
• Have other drivers such as thyroid, cortisol or current medicines been checked
• What is the plan for the phase afterwards, whether after stopping medicine or after surgery
• Who monitors nutrients and body composition, and how often
• Can you commit to follow-up for years, not months

For the full picture of the doctor-led programme and where GLP-1 therapy fits, see doctor-led GLP-1 and weight management.

The health-risk background for body weight sits in the WHO fact sheet.

Every iLIV guide is written and reviewed under our editorial standards, and each one carries the name of the reviewing doctor together with their MMC registration number.

Frequently Asked